Article
Specific Aneuploidies Predict Immune Evasion and Poor Immunotherapy Response in Melanoma
2026-04-15
Abstract excerpt
Melanoma is one of the leading cancer types treated with immune checkpoint blockade (ICB), yet a substantial proportion of patients fail to respond. While tumor mutational burden and PD-L1 expression are established ICB biomarkers, they leave large gaps in predictive accuracy. Somatic copy number alterations (SCNAs) are pervasive in melanoma but their role in shaping the tumor immune microenvironment (TME) and pre...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c65c37dc-21af-5f16-862d-f4a81dcbbc13
- DOI
- 10.64898/2026.04.12.718039
